(Q40329899)

19 September 2017

title

Cardioprotective role for angiotensin-(1-7) and angiotensin converting enzyme 2 in the heart (English)

1 reference

19 September 2017

E Ann Tallant

1

1 reference

19 September 2017

Carlos M Ferrario

series ordinal

2

1 reference

19 September 2017

Patricia E Gallagher

series ordinal

3

1 reference

19 September 2017

publication date

1 May 2006

1 reference

19 September 2017

1 reference

19 September 2017

volume

2

1 reference

19 September 2017

issue

3

1 reference

19 September 2017

page(s)

335-342

1 reference

Release of vasopressin from the rat hypothalamo-neurohypophysial system by angiotensin-(1-7) heptapeptide

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.3.335

In vivo metabolism of angiotensin I by neutral endopeptidase (EC 3.4.24.11) in spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.3.335

State-of-the-Art lecture. Antiproliferative actions of angiotensin-(1-7) in vascular smooth muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.3.335

Angiotensin-(1-7): an update.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.3.335

Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.3.335

Angiotensin-(1-7) inhibits growth of cardiac myocytes through activation of the mas receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.3.335

The renin-angiotensin system during acute myocardial ischemia in dogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.3.335

Angiotensin peptides modulate bradykinin levels in the interstitium of the dog heart in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.3.335

Angiotensin-(1-7): cardioprotective effect in myocardial ischemia/reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.3.335

Expression of an angiotensin-(1-7)-producing fusion protein produces cardioprotective effects in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.3.335

Angiotensin (1-7) re-establishes impulse conduction in cardiac muscle during ischaemia-reperfusion. The role of the sodium pump

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.3.335

Angiotensin-(1-7) binds to specific receptors on cardiac fibroblasts to initiate antifibrotic and antitrophic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.3.335

A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.3.335

ACEH/ACE2 is a novel mammalian metallocarboxypeptidase and a homologue of angiotensin-converting enzyme insensitive to ACE inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.3.335

A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.3.335

Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.3.335

Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2).

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.3.335

Angiotensin-converting enzyme 2 is an essential regulator of heart function

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.3.335

Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.3.335

ACE2: from vasopeptidase to SARS virus receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.3.335

Protection from angiotensin II-induced cardiac hypertrophy and fibrosis by systemic lentiviral delivery of ACE2 in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.3.335

Heart block, ventricular tachycardia, and sudden death in ACE2 transgenic mice with downregulated connexins

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.3.335

Angiotensin-(1-7) formation in the intact human heart: in vivo dependence on angiotensin II as substrate

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.3.335

Increased angiotensin-(1-7)-forming activity in failing human heart ventricles: evidence for upregulation of the angiotensin-converting enzyme Homologue ACE2.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.3.335

ACE2 gene expression is up-regulated in the human failing heart

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.3.335

Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.3.335

Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.3.335

Chronic infusion of angiotensin-(1-7) reduces heart angiotensin II levels in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.3.335

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.3.335

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.3.335

Aldosterone stimulates angiotensin-converting enzyme expression and activity in rat neonatal cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.3.335

Aldosterone induces angiotensin-converting-enzyme gene expression in cultured neonatal rat cardiocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.3.335

Effects of spironolactone and eprosartan on cardiac remodeling and angiotensin-converting enzyme isoforms in rats with experimental heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.3.335

Mineralocorticoid receptor blocker increases angiotensin-converting enzyme 2 activity in congestive heart failure patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.3.335

Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1-7) in regulation of cardiovascular function

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.3.335

Distinct roles for ANG II and ANG-(1-7) in the regulation of angiotensin-converting enzyme 2 in rat astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.2.3.335

21 January 2018

Identifiers

DOI

10.2217/14796678.2.3.335

1 reference

19 September 2017

1 reference